

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.15196874 |
| 2 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.80463411 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.75314694 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.72935713 |
| 5 | gamma-aminobutyric acid transport (GO:0015812) | 4.67540755 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.57069902 |
| 7 | vocalization behavior (GO:0071625) | 4.51453053 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 4.50240440 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.46599167 |
| 10 | L-amino acid import (GO:0043092) | 4.42867179 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.35222481 |
| 12 | glutamate secretion (GO:0014047) | 4.27122570 |
| 13 | alanine transport (GO:0032328) | 4.21667472 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.19311245 |
| 15 | sodium ion export (GO:0071436) | 4.12562470 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.10547407 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.03222686 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.97884182 |
| 19 | amino acid import (GO:0043090) | 3.95468511 |
| 20 | response to auditory stimulus (GO:0010996) | 3.93904134 |
| 21 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.89681334 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.88438554 |
| 23 | neurotransmitter secretion (GO:0007269) | 3.87117261 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.85334981 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.82082450 |
| 26 | cell communication by electrical coupling (GO:0010644) | 3.80429336 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 3.77346180 |
| 28 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.76633753 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.76319360 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.75415304 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.71813162 |
| 32 | exploration behavior (GO:0035640) | 3.71175864 |
| 33 | protein localization to synapse (GO:0035418) | 3.70486941 |
| 34 | proline transport (GO:0015824) | 3.70018274 |
| 35 | C4-dicarboxylate transport (GO:0015740) | 3.62991417 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.60225135 |
| 37 | auditory behavior (GO:0031223) | 3.56714175 |
| 38 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.54051909 |
| 39 | long-term memory (GO:0007616) | 3.53697070 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.51056196 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.50930517 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.50928532 |
| 43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.48497346 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48441329 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48138041 |
| 46 | regulation of synaptic vesicle transport (GO:1902803) | 3.46299648 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.43221726 |
| 48 | membrane depolarization during action potential (GO:0086010) | 3.38242495 |
| 49 | transmission of nerve impulse (GO:0019226) | 3.37741735 |
| 50 | layer formation in cerebral cortex (GO:0021819) | 3.37047364 |
| 51 | negative regulation of astrocyte differentiation (GO:0048712) | 3.36455506 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.34560978 |
| 53 | regulation of beta-amyloid formation (GO:1902003) | 3.33744736 |
| 54 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.33244897 |
| 55 | potassium ion import (GO:0010107) | 3.31475489 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.29245469 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28014534 |
| 58 | regulation of neurotransmitter uptake (GO:0051580) | 3.26086416 |
| 59 | neurotransmitter transport (GO:0006836) | 3.24345977 |
| 60 | neuronal ion channel clustering (GO:0045161) | 3.19148455 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.18787860 |
| 62 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18340023 |
| 63 | cellular sodium ion homeostasis (GO:0006883) | 3.18081656 |
| 64 | dendritic spine morphogenesis (GO:0060997) | 3.16593691 |
| 65 | glycine transport (GO:0015816) | 3.16337132 |
| 66 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.15571344 |
| 67 | serotonin metabolic process (GO:0042428) | 3.14339120 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 3.11495527 |
| 69 | primary amino compound metabolic process (GO:1901160) | 3.10077105 |
| 70 | cerebellar granule cell differentiation (GO:0021707) | 3.09419597 |
| 71 | acidic amino acid transport (GO:0015800) | 3.08994009 |
| 72 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.08935390 |
| 73 | regulation of synapse maturation (GO:0090128) | 3.08230018 |
| 74 | positive regulation of membrane potential (GO:0045838) | 3.08176581 |
| 75 | synaptic vesicle endocytosis (GO:0048488) | 3.07659605 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.05114232 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 3.04493965 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.04417091 |
| 79 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04362342 |
| 80 | neurotransmitter uptake (GO:0001504) | 3.03331858 |
| 81 | membrane depolarization (GO:0051899) | 3.02691599 |
| 82 | regulation of synaptic plasticity (GO:0048167) | 3.00992677 |
| 83 | neuromuscular process controlling balance (GO:0050885) | 3.00310182 |
| 84 | potassium ion homeostasis (GO:0055075) | 2.99916620 |
| 85 | regulation of dendritic spine development (GO:0060998) | 2.99675710 |
| 86 | presynaptic membrane organization (GO:0097090) | 2.99606879 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 2.99185992 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.96312320 |
| 89 | behavioral response to nicotine (GO:0035095) | 2.95252166 |
| 90 | chondroitin sulfate catabolic process (GO:0030207) | 2.93917202 |
| 91 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89800809 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89411174 |
| 93 | positive regulation of dendritic spine development (GO:0060999) | 2.85803089 |
| 94 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.85311272 |
| 95 | prepulse inhibition (GO:0060134) | 2.84908849 |
| 96 | mechanosensory behavior (GO:0007638) | 2.84875387 |
| 97 | negative regulation of dendrite development (GO:2000171) | 2.84689604 |
| 98 | dendrite morphogenesis (GO:0048813) | 2.84059167 |
| 99 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83828004 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82619882 |
| 101 | synaptic transmission (GO:0007268) | 2.80375361 |
| 102 | L-glutamate transport (GO:0015813) | 2.78823393 |
| 103 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.78501049 |
| 104 | regulation of neurotransmitter secretion (GO:0046928) | 2.77394577 |
| 105 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.76752005 |
| 106 | central nervous system myelination (GO:0022010) | 2.76200494 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 2.76200494 |
| 108 | startle response (GO:0001964) | 2.75943213 |
| 109 | cellular potassium ion transport (GO:0071804) | 2.75799250 |
| 110 | potassium ion transmembrane transport (GO:0071805) | 2.75799250 |
| 111 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.74647818 |
| 112 | membrane repolarization (GO:0086009) | 2.74479817 |
| 113 | regulation of respiratory system process (GO:0044065) | 2.73275689 |
| 114 | regulation of vesicle fusion (GO:0031338) | 2.71993351 |
| 115 | cellular response to cholesterol (GO:0071397) | 2.71941270 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.71719466 |
| 117 | positive regulation of synaptic transmission (GO:0050806) | 2.71699829 |
| 118 | regulation of synaptic transmission (GO:0050804) | 2.68666704 |
| 119 | negative regulation of sodium ion transport (GO:0010766) | 2.68504552 |
| 120 | adult walking behavior (GO:0007628) | 2.68188243 |
| 121 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.67703110 |
| 122 | cell differentiation in hindbrain (GO:0021533) | 2.67365784 |
| 123 | low-density lipoprotein particle remodeling (GO:0034374) | 2.66992709 |
| 124 | positive regulation of dendrite development (GO:1900006) | 2.66122706 |
| 125 | exogenous drug catabolic process (GO:0042738) | 2.65293720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.48515591 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.15596092 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12967281 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08507812 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00778295 |
| 6 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.74002840 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73220618 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73220618 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66153964 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56914140 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55952178 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.54116198 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46515524 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46335312 |
| 15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39020782 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37381778 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35448771 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.23000084 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22666875 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22389314 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20429861 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.17660115 |
| 23 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02370034 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95726690 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91720601 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75464263 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62740555 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57939025 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.56171775 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52490898 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50123839 |
| 32 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46252875 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.45896625 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44874007 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44150889 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41181938 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41156873 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38984590 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37367283 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36854722 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35988818 |
| 42 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34504507 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33056056 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32888499 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32664849 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32403367 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29180207 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23399403 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23355237 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21681592 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21564292 |
| 52 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20477929 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20477929 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17075479 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16629260 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16286900 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13602670 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13275835 |
| 59 | AR_19668381_ChIP-Seq_PC3_Human | 1.12776529 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10361148 |
| 61 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10070486 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09698616 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08752016 |
| 64 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08620851 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08616930 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08288172 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06273679 |
| 68 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05444218 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04668778 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04419090 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03578149 |
| 72 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03564337 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01478038 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01365016 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00783847 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00179578 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00098971 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99393223 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98644761 |
| 80 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96814064 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95882472 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94981613 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94505533 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94418344 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94045449 |
| 86 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93782390 |
| 87 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93629006 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93288208 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92912700 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92417821 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92250634 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92066687 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91566902 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90219294 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88953183 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88689359 |
| 97 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88180460 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87852287 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87277840 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86763328 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86254701 |
| 102 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86239825 |
| 103 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86069456 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85812878 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84728815 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84725839 |
| 107 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.84542079 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83985813 |
| 109 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83825860 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83786812 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82742191 |
| 112 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82062377 |
| 113 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81735767 |
| 114 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.81371132 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80079097 |
| 116 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.80061803 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79251532 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.79047803 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.78514989 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.78146748 |
| 121 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77441914 |
| 122 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.77239590 |
| 123 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.76954292 |
| 124 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.76954292 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76001582 |
| 126 | KDM2B_26808549_Chip-Seq_REH_Human | 0.75931540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.49109861 |
| 2 | MP0003880_abnormal_central_pattern | 3.77629215 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.68156718 |
| 4 | MP0009745_abnormal_behavioral_response | 3.15525958 |
| 5 | MP0009046_muscle_twitch | 3.15448096 |
| 6 | MP0004270_analgesia | 3.08269621 |
| 7 | MP0002064_seizures | 2.97335294 |
| 8 | MP0001486_abnormal_startle_reflex | 2.88656522 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.85728456 |
| 10 | MP0004858_abnormal_nervous_system | 2.58206390 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.56779919 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.56128727 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.54925471 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.51460752 |
| 15 | MP0003690_abnormal_glial_cell | 2.48387540 |
| 16 | MP0003329_amyloid_beta_deposits | 2.46888559 |
| 17 | MP0002272_abnormal_nervous_system | 2.42919959 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.28722808 |
| 19 | MP0008569_lethality_at_weaning | 2.27552402 |
| 20 | MP0003136_yellow_coat_color | 2.10697113 |
| 21 | MP0002822_catalepsy | 2.09934331 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.05376171 |
| 23 | MP0004885_abnormal_endolymph | 2.02976777 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.02207363 |
| 25 | MP0002736_abnormal_nociception_after | 2.02065918 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.98209501 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.97993277 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.92085732 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.82754064 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.82018949 |
| 31 | MP0001970_abnormal_pain_threshold | 1.81056384 |
| 32 | MP0001984_abnormal_olfaction | 1.80217084 |
| 33 | MP0001502_abnormal_circadian_rhythm | 1.78151047 |
| 34 | MP0000778_abnormal_nervous_system | 1.62383822 |
| 35 | MP0003633_abnormal_nervous_system | 1.62119121 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.59534195 |
| 37 | MP0004142_abnormal_muscle_tone | 1.58634821 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.54812075 |
| 39 | MP0002653_abnormal_ependyma_morphology | 1.54347906 |
| 40 | MP0003195_calcinosis | 1.52714579 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52466982 |
| 42 | MP0003787_abnormal_imprinting | 1.52290954 |
| 43 | MP0003075_altered_response_to | 1.50176569 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.45849131 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.43669847 |
| 46 | MP0004924_abnormal_behavior | 1.43669847 |
| 47 | MP0003634_abnormal_glial_cell | 1.40006852 |
| 48 | MP0003631_nervous_system_phenotype | 1.39255311 |
| 49 | MP0000955_abnormal_spinal_cord | 1.37753870 |
| 50 | MP0002184_abnormal_innervation | 1.36339456 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.31685611 |
| 52 | MP0000604_amyloidosis | 1.30269238 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.29867782 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.24038474 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.23206611 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.19999274 |
| 57 | MP0003632_abnormal_nervous_system | 1.19043302 |
| 58 | MP0004147_increased_porphyrin_level | 1.18496000 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.17576758 |
| 60 | MP0000920_abnormal_myelination | 1.15804161 |
| 61 | MP0003879_abnormal_hair_cell | 1.14645038 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.14639950 |
| 63 | MP0002254_reproductive_system_inflammat | 1.14373805 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.11374376 |
| 65 | MP0003122_maternal_imprinting | 1.10624775 |
| 66 | MP0008877_abnormal_DNA_methylation | 1.09910279 |
| 67 | MP0001905_abnormal_dopamine_level | 1.09188950 |
| 68 | MP0005365_abnormal_bile_salt | 1.08391975 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.08359055 |
| 70 | MP0002229_neurodegeneration | 1.07853008 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.05240868 |
| 72 | MP0005171_absent_coat_pigmentation | 1.04616984 |
| 73 | MP0001177_atelectasis | 1.00623080 |
| 74 | MP0002152_abnormal_brain_morphology | 1.00119871 |
| 75 | MP0003011_delayed_dark_adaptation | 0.99712504 |
| 76 | MP0004742_abnormal_vestibular_system | 0.99174950 |
| 77 | MP0004133_heterotaxia | 0.97093882 |
| 78 | MP0005535_abnormal_body_temperature | 0.94404090 |
| 79 | MP0005409_darkened_coat_color | 0.93832465 |
| 80 | MP0002090_abnormal_vision | 0.93198258 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 0.90931034 |
| 82 | MP0003878_abnormal_ear_physiology | 0.90931034 |
| 83 | MP0008874_decreased_physiological_sensi | 0.87879276 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.86378571 |
| 85 | MP0001188_hyperpigmentation | 0.85731753 |
| 86 | MP0008872_abnormal_physiological_respon | 0.85358271 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.81649326 |
| 88 | MP0001529_abnormal_vocalization | 0.81545580 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.81503869 |
| 90 | MP0000026_abnormal_inner_ear | 0.79791148 |
| 91 | MP0003283_abnormal_digestive_organ | 0.79117527 |
| 92 | MP0005253_abnormal_eye_physiology | 0.78612777 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.77662498 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.76968755 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.76155490 |
| 96 | MP0005332_abnormal_amino_acid | 0.71883871 |
| 97 | MP0003252_abnormal_bile_duct | 0.71349219 |
| 98 | MP0006292_abnormal_olfactory_placode | 0.71132407 |
| 99 | MP0005499_abnormal_olfactory_system | 0.70716070 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.70716070 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.70240625 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.69806028 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.68646838 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.67986862 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.67030293 |
| 106 | MP0000566_synostosis | 0.66079789 |
| 107 | MP0004043_abnormal_pH_regulation | 0.65903286 |
| 108 | MP0000751_myopathy | 0.65369012 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.64545932 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.63551639 |
| 111 | MP0001664_abnormal_digestion | 0.62534483 |
| 112 | MP0004130_abnormal_muscle_cell | 0.62506633 |
| 113 | MP0009840_abnormal_foam_cell | 0.60813918 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.60470930 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.58316832 |
| 116 | MP0005448_abnormal_energy_balance | 0.57695513 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.57656015 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.57549621 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.57385253 |
| 120 | MP0005166_decreased_susceptibility_to | 0.55076346 |
| 121 | MP0004085_abnormal_heartbeat | 0.54630231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.93505520 |
| 2 | Myokymia (HP:0002411) | 6.45789181 |
| 3 | Megalencephaly (HP:0001355) | 5.26624479 |
| 4 | Action tremor (HP:0002345) | 4.76800291 |
| 5 | Aplasia involving bones of the extremities (HP:0009825) | 4.70051515 |
| 6 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.70051515 |
| 7 | Aplasia of the phalanges of the hand (HP:0009802) | 4.70051515 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.61882950 |
| 9 | Focal seizures (HP:0007359) | 4.60782003 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.27030346 |
| 11 | Visual hallucinations (HP:0002367) | 3.82843587 |
| 12 | Febrile seizures (HP:0002373) | 3.75242110 |
| 13 | Dysdiadochokinesis (HP:0002075) | 3.72208919 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.72142064 |
| 15 | Hemiplegia (HP:0002301) | 3.67119254 |
| 16 | Hemiparesis (HP:0001269) | 3.57823444 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.52892740 |
| 18 | Diplopia (HP:0000651) | 3.48578760 |
| 19 | Abnormality of binocular vision (HP:0011514) | 3.48578760 |
| 20 | Atonic seizures (HP:0010819) | 3.47871171 |
| 21 | Status epilepticus (HP:0002133) | 3.31060059 |
| 22 | Abnormal eating behavior (HP:0100738) | 3.30879465 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.27970049 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.26591676 |
| 25 | Absence seizures (HP:0002121) | 3.19164905 |
| 26 | Depression (HP:0000716) | 3.12201125 |
| 27 | Anxiety (HP:0000739) | 3.06225397 |
| 28 | Dialeptic seizures (HP:0011146) | 3.00505756 |
| 29 | Postural instability (HP:0002172) | 2.98987281 |
| 30 | Scanning speech (HP:0002168) | 2.94973247 |
| 31 | Dysmetria (HP:0001310) | 2.92975722 |
| 32 | Hyperventilation (HP:0002883) | 2.84006463 |
| 33 | Truncal ataxia (HP:0002078) | 2.83716828 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.76145304 |
| 35 | Ankle clonus (HP:0011448) | 2.71551045 |
| 36 | Split foot (HP:0001839) | 2.71223499 |
| 37 | Intention tremor (HP:0002080) | 2.68943720 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.63960712 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54164433 |
| 40 | Polyphagia (HP:0002591) | 2.51321681 |
| 41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50558051 |
| 42 | Broad-based gait (HP:0002136) | 2.49652332 |
| 43 | Genetic anticipation (HP:0003743) | 2.49508812 |
| 44 | Limb dystonia (HP:0002451) | 2.46351004 |
| 45 | Polydipsia (HP:0001959) | 2.40197305 |
| 46 | Abnormal drinking behavior (HP:0030082) | 2.40197305 |
| 47 | Hypomagnesemia (HP:0002917) | 2.34371223 |
| 48 | Decreased central vision (HP:0007663) | 2.31153210 |
| 49 | Clumsiness (HP:0002312) | 2.29687288 |
| 50 | Bradykinesia (HP:0002067) | 2.29437877 |
| 51 | Humeroradial synostosis (HP:0003041) | 2.29266935 |
| 52 | Synostosis involving the elbow (HP:0003938) | 2.29266935 |
| 53 | Impaired vibratory sensation (HP:0002495) | 2.28922183 |
| 54 | Poor eye contact (HP:0000817) | 2.27339949 |
| 55 | Torticollis (HP:0000473) | 2.25582855 |
| 56 | Abnormal social behavior (HP:0012433) | 2.19909107 |
| 57 | Impaired social interactions (HP:0000735) | 2.19909107 |
| 58 | Clonus (HP:0002169) | 2.19639166 |
| 59 | Polyuria (HP:0000103) | 2.19263744 |
| 60 | Spastic gait (HP:0002064) | 2.17123526 |
| 61 | Abnormality of the axillary hair (HP:0100134) | 2.17108189 |
| 62 | Abnormality of secondary sexual hair (HP:0009888) | 2.17108189 |
| 63 | True hermaphroditism (HP:0010459) | 2.15767340 |
| 64 | Blue irides (HP:0000635) | 2.15314826 |
| 65 | Focal dystonia (HP:0004373) | 2.13533381 |
| 66 | Amblyopia (HP:0000646) | 2.12650887 |
| 67 | Congenital stationary night blindness (HP:0007642) | 2.12581363 |
| 68 | Limb ataxia (HP:0002070) | 2.10783520 |
| 69 | Impaired smooth pursuit (HP:0007772) | 2.09274387 |
| 70 | Papilledema (HP:0001085) | 2.06229940 |
| 71 | Type II lissencephaly (HP:0007260) | 2.05986086 |
| 72 | Hypoplastic left heart (HP:0004383) | 2.05417926 |
| 73 | Abnormal urine output (HP:0012590) | 2.05083713 |
| 74 | Rigidity (HP:0002063) | 2.05038487 |
| 75 | Sleep apnea (HP:0010535) | 2.04567484 |
| 76 | Stereotypic behavior (HP:0000733) | 2.03689777 |
| 77 | Agitation (HP:0000713) | 2.03057532 |
| 78 | Pancreatic cysts (HP:0001737) | 2.01722512 |
| 79 | Protruding tongue (HP:0010808) | 2.01448059 |
| 80 | Abnormality of saccadic eye movements (HP:0000570) | 2.01366189 |
| 81 | Absent speech (HP:0001344) | 2.00553520 |
| 82 | Anomalous pulmonary venous return (HP:0010772) | 2.00179160 |
| 83 | Lower limb muscle weakness (HP:0007340) | 1.99985201 |
| 84 | Metabolic alkalosis (HP:0200114) | 1.99955132 |
| 85 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99889534 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 1.99423709 |
| 87 | Pheochromocytoma (HP:0002666) | 1.99376802 |
| 88 | Epileptiform EEG discharges (HP:0011182) | 1.97968855 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96688791 |
| 90 | Inability to walk (HP:0002540) | 1.96315642 |
| 91 | Dysmetric saccades (HP:0000641) | 1.95518263 |
| 92 | Hyperglycinuria (HP:0003108) | 1.93194719 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92838075 |
| 94 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92397963 |
| 95 | Abnormality of midbrain morphology (HP:0002418) | 1.91057474 |
| 96 | Molar tooth sign on MRI (HP:0002419) | 1.91057474 |
| 97 | Psychosis (HP:0000709) | 1.90830579 |
| 98 | Spastic tetraparesis (HP:0001285) | 1.90791007 |
| 99 | Gait ataxia (HP:0002066) | 1.89835059 |
| 100 | Hypsarrhythmia (HP:0002521) | 1.89675287 |
| 101 | Pancreatic fibrosis (HP:0100732) | 1.89277156 |
| 102 | Abnormality of magnesium homeostasis (HP:0004921) | 1.86827507 |
| 103 | Narrow nasal bridge (HP:0000446) | 1.86094735 |
| 104 | Craniofacial dystonia (HP:0012179) | 1.84928712 |
| 105 | Progressive inability to walk (HP:0002505) | 1.84777791 |
| 106 | Severe global developmental delay (HP:0011344) | 1.84407861 |
| 107 | Confusion (HP:0001289) | 1.81040440 |
| 108 | Postural tremor (HP:0002174) | 1.80326928 |
| 109 | Alkalosis (HP:0001948) | 1.78716581 |
| 110 | Increased circulating renin level (HP:0000848) | 1.78174899 |
| 111 | Akinesia (HP:0002304) | 1.77970065 |
| 112 | Mutism (HP:0002300) | 1.77467877 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.77359996 |
| 114 | Delusions (HP:0000746) | 1.77307635 |
| 115 | Urinary urgency (HP:0000012) | 1.76969379 |
| 116 | Long nose (HP:0003189) | 1.76595734 |
| 117 | Drooling (HP:0002307) | 1.75342060 |
| 118 | Excessive salivation (HP:0003781) | 1.75342060 |
| 119 | Dementia (HP:0000726) | 1.75270664 |
| 120 | Tetraplegia (HP:0002445) | 1.75139739 |
| 121 | Attenuation of retinal blood vessels (HP:0007843) | 1.74644032 |
| 122 | Morphological abnormality of the inner ear (HP:0011390) | 1.74567112 |
| 123 | Nephronophthisis (HP:0000090) | 1.74324020 |
| 124 | Dyskinesia (HP:0100660) | 1.74127353 |
| 125 | Abnormality of glycine metabolism (HP:0010895) | 1.73628403 |
| 126 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73628403 |
| 127 | Hypokalemic alkalosis (HP:0001949) | 1.72992525 |
| 128 | Obstructive sleep apnea (HP:0002870) | 1.71415673 |
| 129 | Annular pancreas (HP:0001734) | 1.71258947 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70877979 |
| 131 | Abnormality of the diencephalon (HP:0010662) | 1.69845698 |
| 132 | Complement deficiency (HP:0004431) | 1.69418437 |
| 133 | Mixed hearing impairment (HP:0000410) | 1.69402918 |
| 134 | Hyperglycinemia (HP:0002154) | 1.69363965 |
| 135 | Intellectual disability, severe (HP:0010864) | 1.69153375 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.68538128 |
| 137 | Fetal akinesia sequence (HP:0001989) | 1.67721194 |
| 138 | Neuronal loss in central nervous system (HP:0002529) | 1.66257215 |
| 139 | Peripheral hypomyelination (HP:0007182) | 1.64089770 |
| 140 | Neuroendocrine neoplasm (HP:0100634) | 1.62555250 |
| 141 | Bronchomalacia (HP:0002780) | 1.62398617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.68005695 |
| 2 | NTRK3 | 3.61105426 |
| 3 | TNIK | 3.24761016 |
| 4 | NTRK2 | 3.07835189 |
| 5 | CASK | 3.05650022 |
| 6 | LMTK2 | 2.93365925 |
| 7 | FRK | 2.89735987 |
| 8 | PRKD3 | 2.69916781 |
| 9 | MAP2K7 | 2.34276629 |
| 10 | MAP3K9 | 2.33621507 |
| 11 | MINK1 | 2.27124096 |
| 12 | PHKG1 | 2.25643270 |
| 13 | PHKG2 | 2.25643270 |
| 14 | PRPF4B | 2.16402197 |
| 15 | MAP3K4 | 2.12451421 |
| 16 | DAPK2 | 2.02136093 |
| 17 | MARK1 | 2.01231836 |
| 18 | MAPK13 | 1.79728335 |
| 19 | SGK2 | 1.79341834 |
| 20 | CAMKK1 | 1.72701354 |
| 21 | PAK6 | 1.70624924 |
| 22 | SGK223 | 1.70135189 |
| 23 | SGK494 | 1.70135189 |
| 24 | PINK1 | 1.55963365 |
| 25 | MUSK | 1.55019982 |
| 26 | MAP2K4 | 1.52515021 |
| 27 | NTRK1 | 1.49399552 |
| 28 | SGK3 | 1.44475175 |
| 29 | PRKCG | 1.40085314 |
| 30 | WNK4 | 1.36950981 |
| 31 | CDK5 | 1.36458297 |
| 32 | FES | 1.30978185 |
| 33 | STK38 | 1.29447373 |
| 34 | ADRBK2 | 1.26662534 |
| 35 | RIPK4 | 1.25200258 |
| 36 | CAMKK2 | 1.23614325 |
| 37 | CDK19 | 1.12400479 |
| 38 | PRKCH | 1.10888504 |
| 39 | KSR2 | 1.07972059 |
| 40 | MAP2K6 | 1.04843809 |
| 41 | MAP3K12 | 1.04841910 |
| 42 | GRK5 | 0.99351790 |
| 43 | CAMK1 | 0.95784496 |
| 44 | MKNK2 | 0.93330945 |
| 45 | CAMK2A | 0.93095840 |
| 46 | TNK2 | 0.87755846 |
| 47 | MAPK12 | 0.87308704 |
| 48 | TYRO3 | 0.87271054 |
| 49 | MAP3K13 | 0.85856803 |
| 50 | SIK2 | 0.85675494 |
| 51 | INSRR | 0.84288276 |
| 52 | TLK1 | 0.81552439 |
| 53 | SIK1 | 0.81279891 |
| 54 | NEK6 | 0.81087899 |
| 55 | PLK2 | 0.78739093 |
| 56 | ARAF | 0.77436610 |
| 57 | GRK1 | 0.76796434 |
| 58 | KSR1 | 0.76454122 |
| 59 | STK39 | 0.75933233 |
| 60 | DAPK1 | 0.75788914 |
| 61 | OXSR1 | 0.75727958 |
| 62 | DYRK1A | 0.75115722 |
| 63 | CAMK2B | 0.75001104 |
| 64 | MAP3K11 | 0.74997826 |
| 65 | SGK1 | 0.74896082 |
| 66 | ERBB2 | 0.74247160 |
| 67 | UHMK1 | 0.74096430 |
| 68 | BMPR2 | 0.72497154 |
| 69 | CAMK2G | 0.71644071 |
| 70 | FGR | 0.70856702 |
| 71 | CDK15 | 0.69070991 |
| 72 | PIK3CA | 0.69041865 |
| 73 | STK11 | 0.68304498 |
| 74 | CDK18 | 0.67980949 |
| 75 | PRKCE | 0.66337994 |
| 76 | CDK14 | 0.65722939 |
| 77 | CAMK1D | 0.64919808 |
| 78 | WNK3 | 0.62168645 |
| 79 | CDK11A | 0.59002748 |
| 80 | PTK2B | 0.58275250 |
| 81 | TAOK3 | 0.57793430 |
| 82 | MAP3K2 | 0.56954937 |
| 83 | ZAK | 0.55278915 |
| 84 | BMPR1B | 0.53930248 |
| 85 | PDPK1 | 0.53267753 |
| 86 | PRKD2 | 0.52662514 |
| 87 | IRAK2 | 0.52126256 |
| 88 | MAP4K2 | 0.51908923 |
| 89 | PAK3 | 0.51494301 |
| 90 | WNK1 | 0.51345448 |
| 91 | RPS6KA3 | 0.50215786 |
| 92 | ADRBK1 | 0.49640757 |
| 93 | RIPK1 | 0.49392127 |
| 94 | PDK1 | 0.48923909 |
| 95 | TRIB3 | 0.48616359 |
| 96 | PRKCZ | 0.48062522 |
| 97 | DYRK2 | 0.47817613 |
| 98 | ROCK2 | 0.47780021 |
| 99 | ROCK1 | 0.45876611 |
| 100 | MARK2 | 0.45697964 |
| 101 | CAMK2D | 0.45537659 |
| 102 | RET | 0.45501045 |
| 103 | CAMK4 | 0.45202808 |
| 104 | MAP3K7 | 0.45192380 |
| 105 | CSNK1G2 | 0.44693331 |
| 106 | PNCK | 0.43138965 |
| 107 | MAPK7 | 0.43124149 |
| 108 | CSNK1D | 0.42091506 |
| 109 | CDC42BPA | 0.41943548 |
| 110 | FGFR2 | 0.41759325 |
| 111 | PRKACA | 0.41110579 |
| 112 | PRKCA | 0.41002342 |
| 113 | MAPK15 | 0.40489631 |
| 114 | PRKACG | 0.40067555 |
| 115 | MAPKAPK5 | 0.39604409 |
| 116 | FYN | 0.39461643 |
| 117 | BMX | 0.38359301 |
| 118 | MAPK8 | 0.38210121 |
| 119 | BRSK1 | 0.36842102 |
| 120 | PRKG1 | 0.36387029 |
| 121 | PRKCQ | 0.35771774 |
| 122 | ALK | 0.35077602 |
| 123 | TXK | 0.34538628 |
| 124 | CAMK1G | 0.34240955 |
| 125 | MAPK10 | 0.34071305 |
| 126 | PKN1 | 0.28907898 |
| 127 | PRKCB | 0.28847171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.49723629 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.35038477 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57118032 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.49852117 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47610768 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.44498283 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26608758 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24008933 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.18694506 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.18093053 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.14137575 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.00774299 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89949649 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.83650379 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81767364 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75572512 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73473708 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.71239005 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63413854 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57150274 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.50979597 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.50568763 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.45462558 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44799371 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41586605 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39167633 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.29023108 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27675770 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24236345 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23045022 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.22765669 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22351425 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20133963 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.19820633 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17280675 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16689854 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14455192 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12664982 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.12299814 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12062971 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11854769 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11241247 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10158419 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06109146 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04508886 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03292295 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.01611852 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01326730 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98316882 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.94749969 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94132335 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.89940229 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88938498 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88098937 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87755434 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87571402 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83528419 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82537181 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82277479 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80733503 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80571585 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78971880 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78539576 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77968106 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76915981 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75407193 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74602325 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72500389 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71096016 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70739995 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70398850 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66895977 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66848625 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66308229 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66174573 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66120394 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65284106 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.65180300 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64926727 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64250477 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.62270896 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62206794 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62143137 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59878842 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57361989 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57325143 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.57133071 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57021615 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53173446 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52900534 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52878575 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50705899 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49728579 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.49134297 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.48085338 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47978206 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47042531 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46067919 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45354406 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43318447 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42928282 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41507993 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41458517 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40625468 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40554904 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38717238 |
| 107 | Peroxisome_Homo sapiens_hsa04146 | 0.37419558 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36927118 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36112226 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.34019797 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33902259 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31826613 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31751167 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31707750 |
| 115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30923580 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30120125 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30033551 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29541864 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29128502 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26841422 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26333074 |

